Please use this identifier to cite or link to this item:
|Title:||Long-term clinical management of depressive disorders.||Austin Authors:||Burrows, Graham D||Affiliation:||Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||1-Mar-1992||Publication information:||The Journal of Clinical Psychiatry; 53 Suppl(): 32-5||Abstract:||The author provides evidence that depression is an often chronic and recurrent illness. He then provides World Health Organization (WHO) and other well-established recommendations for acute treatment of depression and describes maintenance treatment, which usually lasts 3 to 6 months. He lists WHO recommendations for prophylaxis, which should probably be continued for 2 or more years in patients with chronic depression, and reviews the following problems commonly associated with continued antidepressant treatment: cardiac toxicity, drug overdose, suicide/parasuicide, drug toxicity, drug interactions, and noncompliance. Finally, the author discusses discontinuation, which should always be accomplished according to a tapered, individualized schedule with the patient as an active partner in the process. Despite this knowledge, researchers must look for additional therapies for the one third of depressed patients who are not helped by currently available measures.||Gov't Doc #:||1548254||URI:||http://ahro.austin.org.au/austinjspui/handle/1/9820||URL:||https://pubmed.ncbi.nlm.nih.gov/1548254||Type:||Journal Article||Subjects:||Antidepressive Agents.adverse effects.therapeutic use
Combined Modality Therapy
Depressive Disorder.drug therapy.prevention & control.psychology
Drug Administration Schedule
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.